Sign in
4

Changes in Ownership

LENZ Therapeutics, Inc. Filed Acc 0000899243-21-027017

Director bought 180,000 shares at $17.00 ($3,060,000)

  • Director acquired 13,871,446 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Jerel Davis Director 2021-06-29 Conversion +12,343,727 14,708,398 I: show line 1 in the form
Jerel Davis Director 2021-06-29 Conversion +1,527,719 1,527,719 I: show line 2 in the form
Jerel Davis Director 2021-06-29 Purchase +180,000 $17.00 $3,060,000 1,707,719 I: show line 3 in the form
Open-market purchases · 180,000 sh · avg $17.00 · $3,060,000

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Jerel Davis Director 2021-06-29 Conversion · Series A Preferred Stock −30,019,945 0 I: show line 4 in the form
Jerel Davis Director 2021-06-29 Conversion · Series B Preferred Stock −3,715,415 0 I: show line 5 in the form
Loading xslF345X03/doc4.xml…